Icon Genetics Inc. Announces Establishment of Icon Genetics AG in Munich, Germany.PRINCETON, N.J.--(BW HealthWire)--Nov. 8, 1999-- Icon Genetics, Inc. announced today the establishment of a new company with headquarters in Munich, Germany. The new entity, Icon Genetics AG, was established to employ the outstanding scientists in Germany and Europe and to take advantage of the excellent facilities and financial opportunities in the area. Upon reorganization Icon Genetics, Inc. will become a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Icon Genetics AG. Scientific research is a worldwide endeavor, especially in agricultural biotechnology; therefore, Icon plans to have research facilities in Germany and in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. to take advantage of a number of opportunities that are now available. Having facilities near major universities, research institutes and in attractive areas will mean that Icon can provide the best opportunities for its employees and benefit financially and intellectually at the same time. Germany has implemented a number of incentive programs targeted at attracting biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. into the country, including financial incentives for venture capital companies. Establishing research laboratories in Germany will be a top priority for Icon Genetics over the next few months. Having headquarters in Munich will allow for easier recruitment more rapid growth and the ability to attract top scientists from across Europe and the United States. The Icon Genetics group will open laboratory sites in the Princeton area in New Jersey (USA), as well as Munich and Halle, Germany. The Management Board of Icon Genetics AG will be composed of Yuri Gleba gle·ba n. pl. gle·bae The fleshy, spore-bearing inner mass of a puffball. [Latin gl  ba, clod. , Ph.D. the CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and co-founder of Icon Genetics, Inc., and Dr. Newell Bascomb, Ph.D. President and co-founder of Icon Genetics, Inc. The Supervisory Board Supervisory boardThe board of directors that represents stakeholders in the governance of the corporation. will be composed of Dr. Robert Erwin, CEO of Biosource Technologies, Prof. Dr. Hans-Ulrich Koop, cofounder co·found tr.v. co·found·ed, co·found·ing, co·founds To establish or found in concert with another or others. co·found of Icon Genetics, Inc. (who will serve as Vice Chairman of the Supervisory Board, and will remain as Professor at the Institute of Botany, Munich University), and Prof. Dr. Meinhardt Zenk, Professor, University Halle-Wittenberg, Halle. Icon Genetics, Inc., was founded in February of 1999 and is currently operating research labs in Kiev, Ukraine. The company's focus is to solve problems in transgene transgene a gene that has been incorporated into the genome of another organism. management as agricultural biotechnology enters the postgenomics era. The company strives to bring the speed and efficiency of crop engineering to that of gene discovery by developing products to address the problems of moving transgenes into elite varieties. To learn more about Icon Genetics visit their web site at www.icongenetics.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion